BabyChecker
AI for pregnancy screening with ultrasound
Company profile
Company profile
Delft Imaging is a Netherlands-based social enterprise that develops end-to-end diagnostic solutions designed to bring quality healthcare screening to underserved populations in resource-constrained settings. The company specializes in lung health and maternal health screening, combining portable and mobile X-ray systems with artificial intelligence to enable early detection in hard-to-reach places. Their technology portfolio includes CAD4TB+, an AI system for TB and lung health screening that analyzes chest X-rays within seconds with high accuracy and operates offline. For maternal health, they offer BabyChecker, an AI-enabled ultrasound screening solution. The company also provides a range of X-ray equipment from ultra-portable units to stationary systems, as well as mobile clinic solutions including the Delft Cruiser and Delft TukTuk for remote and densely populated areas respectively. Delft Imaging operates as a B Corp certified social enterprise and is a member of the Million Lives Collective. They work with national TB screening programs, health systems, and community-based organizations to build scalable and sustainable screening models. Their solutions integrate with existing health infrastructure to support decentralized screening, disease surveillance, and occupational health programs. With over 3,000 solutions deployed across 90+ countries, they have reached more than 55 million people worldwide, focusing particularly on key and vulnerable populations in Africa, Asia, Americas, and other regions.
Company description Delft Imaging official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded · On Premise deployment with recorded integration context.
Company milestones
2025 Impact Report released, CAD4TB+ launched (unifying TB detection and surveillance), Florent Geerts named to TIME's 2026 TIME100 Health
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI for pregnancy screening with ultrasound
AI for lung health and TB screening
X-ray for high-quality diagnostic imaging
Reliable screening in remote regions
Portable, easy-to-setup X-ray
Easy transport and flexible positioning mobile X-ray
Screening solution in densely populated areas
Ultra portable, high-quality X-ray
Multipurpose, stationary X-ray
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
BMC pregnancy and childbirth · Apr 27, 2026
Climate-smart radiography in Ghana: training needs of diagnostic radiographers mapped to the WHO operational framework and UNFCCC Action for Climate Empowerment (ACE).BMC health services research · Jan 7, 2026
Contribution of artificial intelligence to the imaging diagnosis of pediatric pulmonary tuberculosis.Revista do Instituto de Medicina Tropical de Sao Paulo · Jan 1, 2026
A mixed-method evaluation of the impact of introducing 52 digital X-ray systems in Ghanaian health facilities on tuberculosis case finding and quality of care.PLOS global public health · Jan 1, 2026
Optimising computer aided detection to identify intra-thoracic tuberculosis on chest x-ray in South African children.PLOS global public health · Jan 1, 2023
Clinical validation
NCT04666311 · Mentioned · COMPLETED
Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South AfricaNCT05526885 · Mentioned · COMPLETED
AI-POCUS for Maternal and Neonatal Health in EthiopiaNCT07171086 · Mentioned · NOT YET RECRUITING
TB Reduction Through ART and TB Screening ProjectNCT03739736 · Sponsor · UNKNOWN
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
global screening programs
across 90+ countries
chest X-ray analysis time with CAD4TB+
TB screening program implementation
National TB screening program implementation
TB screening program implementation
TB screening program implementation
TB screening program implementation
National TB screening program implementation
Leveraging technology for TB screening and healthier future
TB screening program implementation
TB screening program implementation
TB screening program implementation
TB screening program implementation
TB screening program implementation
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Delft Imaging's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.